Chemical and pharmacological aspects of neutralization of heparins from different animal sources by protamine-Reference-Cited by-同舟云学术

Chemical and pharmacological aspects of neutralization of heparins from different animal sources by protamine

Published:2018-08-13 Issue:9 Volume:16 Page:1789-1799
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Glauser B. F.¹,Santos G. R. C.¹²,Silva J. D.¹,Tovar A. M. F.¹,Pereira M. S.¹,Vilanova E.¹,Mourão P. A. S.¹

Affiliation:

1. Laboratório de Tecido Conjuntivo; Hospital Universitário Clementino Fraga Filho and Instituto de Bioquímica Médica Leopoldo de Meis; Universidade Federal do Rio de Janeiro; Cidade Universitária; Rio de Janeiro Brazil

2. Laboratório de Apoio ao Desenvolvimento Tecnológico; Laboratório Brasileiro de Controle de Dopagem; Instituto de Química; Universidade Federal do Rio de Janeiro; Cidade Universitária; Rio de Janeiro Brazil

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.14221/fullpdf

Reference30 articles.

1. Pharmacology of heparin and related drugs;Mulloy;Pharmacol Rev,2016

2. The anticoagulant activation of antithrombin by heparin;Jin;Proc Natl Acad Sci USA,1997

3. Heparin-protein interactions;Linhardt;Angew Chem Int Ed,2002

4. Low-molecular-weight heparins;Weitz;N Engl J Med,1997

5. Heparin-coated extracorporeal circulation systems in heart surgery;Tagarakis;Recent Pat Cardiovasc Drug Discov,2009

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor targeting in situ aggregation of nanoparticle-to-nanoparticle strategy to simultaneously induce ferroptosis and immunogenic cell death using complementary heparin and protamine molecules;Nano Today;2024-08

2. Potency evaluation of unfractionated heparins commercialized in Brazil through anti-factor Xa and anti-factor IIa chromogenic tests and coagulation assay;Vigilância Sanitária em Debate;2023-04-19

3. Pharmacology of Heparin and Related Drugs: An Update;Pharmacological Reviews;2023-02-15

4. Dilemmas in the Choice of Adequate Therapeutic Treatment in Patients with Acute Pulmonary Embolism—From Modern Recommendations to Clinical Application;Pharmaceuticals;2022-09-14

5. Pharmacokinetic, Hemostatic, and Anticancer Properties of a Low-Anticoagulant Bovine Heparin;TH Open;2022-04